MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image David Ying Chen
David Ying ChenEPIPHRON CAPITAL

David Ying Chen

Executive Director, Head of M&A at EPIPHRON CAPITAL

Investor

Deal Bio

Total Deals1
Valued Deals1
Total Value£ 92 M
Avg. Deal Size£ 92 M

Market Context

Sort

24 Feb 2021|China|Biotechnology
Yisheng Biopharma
Adjuvant Capital

Target: YISHENG BIOPHARMA

Bidder: ADJUVANT CAPITAL

16 Service Providers

4 Target | 12 Bidder

12 Dealmakers

2 Target | 10 Bidder

£ 92 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite